Twelve‐week ravidasvir plus ritonavir‐boosted danoprevir and ribavirin for non‐cirrhotic HCV genotype 1 patients: A phase 2 study

Jia‐Horng Kao, Jinzi J. Wu, Chi‐Yi Chen et al.|Journal of Gastroenterology and Hepatology|2018

Cited by 14